ArticleJournal for immunotherapy of cancer2025

Targeting MARCO in combination with anti-CTLA-4 leads to enhanced melanoma regression and immune cell infiltration via macrophage reprogramming.

Hidenori Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.